Physician
Charles W. Nolen, JR., M.D., P.C.
Charles W. Nolen, JR., M.D., P.C. was paid $352K by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 80% of everything it billed.
33Billing provider infoCHARLES W. NOLEN, JR., M.D., P.C.
FAYETTE, AL 35555
FAYETTE, AL 35555
33aNPI1891842514assigned 01/04/2007
33bProvider typeFamily Medicine Physician
28Total paid$352K
24GClaims13,395
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Alabama
Rank by total paid#108 of 455
Median peer was paid$57K
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,768 | $46K | |
| 2019 | 3,109 | $53K | |
| 2020 | 1,554 | $48K | |
| 2021 | 1,779 | $65K | |
| 2022 | 1,720 | $51K | |
| 2023 | 1,604 | $51K | |
| 2024incomplete | 861 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 80% | 4,634 | 3,888 | $281K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.6% | 779 | 678 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.7% | 1,697 | 1,476 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 1,601 | 1,479 | $10K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 199 | 191 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 383 | 363 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 293 | 264 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 72 | 62 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,186 | 1,088 | $2K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 13 | 12 | $909.59 |
| 85651 | <1% | 332 | 321 | $829.00 | |
| 81003 | <1% | 78 | 73 | $138.68 |
10 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 30 | $32.09 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $17.28 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 274 | $0.00 |
| 3074F | 0% | 145 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 739 | $0.00 |
| 3079F | 0% | 16 | $0.00 | |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 351 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 497 | $0.00 |
| 3078F | 0% | 49 | $0.00 | |
| 90756 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNOLEN, JR., CHARLES (OWNER)